Citizens Financial Group Inc Eagle Pharmaceuticals, Inc. Transaction History

Citizens Financial Group Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$37.02 - $51.28 $3,739 - $5,179	-101 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$43.24 - $55.02 $7,567 - $9,628	-175 Reduced 63.41%	101 $5,000
Q4 2019 Feb 07, 2020	BUY	$54.32 - $64.31 $14,992 - $17,749	276 New	276 $17,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Citizens Financial Group Inc with notifications on news.